Alerts will be sent to your verified email
Verify Email
KREBSBIO
|
Krebs Biochem.&Inds
|
Murae Organisor
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
56.46 % | 7.44 % | -352.38 % |
|
5yr average Equity Multiplier
|
-2.97 | 1.97 | 65.1 |
|
5yr Average Asset Turnover Ratio
|
0.3 | 0.85 | 1.17 |
|
5yr Avg Net Profit Margin
|
-60.0 % | 5.88 % | -2.03 % |
|
Price to Book
|
0.0 | 0.58 | 23.9 |
|
P/E
|
0.0 | 26.29 | 20.2 |
|
5yr Avg Cash Conversion Cycle
|
-861.42 Days | 3241.06 Days | 28.76 Days |
|
Inventory Days
|
115.42 Days | 515.14 Days | 94.07 Days |
|
Days Receivable
|
8.79 Days | 1372.66 Days | 101.18 Days |
|
Days Payable
|
408.94 Days | 17.5 Days | 144.79 Days |
|
5yr Average Interest Coverage Ratio
|
-5.02 | 11.0 | 0.28 |
|
5yr Avg ROCE
|
-22.06 % | 12.76 % | -0.98 % |
|
5yr Avg Operating Profit Margin
|
-38.55 % | -13.99 % | 1.32 % |
|
5 yr average Debt to Equity
|
-2.12 | 0.48 | 29.7 |
|
5yr CAGR Net Profit
|
-7.31 % | -51.27 % | n/a |
|
5yr Average Return on Assets
|
-17.59 % | 4.01 % | -2.12 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.74 % | 0.0 | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -50.21 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Krebs Biochem.&Inds
|
Murae Organisor
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|